查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790284

神经血管设备市场规模、份额和趋势分析报告：按设备、治疗用途、规模、最终用途、地区和细分市场预测，2025 年至 2033 年

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Applications, By Size, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

神经血管设备市场摘要

2024 年全球神经血管设备市场价值估计为 73.4 亿美元，预计到 2033 年将达到 119.1 亿美元，2025 年至 2033 年期间的复合年增长率为 5.48%。该市场受到神经血管疾病患病率上升、医疗技术的进步以及对微创手术的日益关注的推动。

随着中风、脑动脉瘤和动静脉畸形 (AVM) 等疾病的日益普遍，对有效治疗方案的需求也日益增长。中风和动脉瘤等神经血管疾病的盛行率不断上升，是神经血管器械产业发展的主要驱动力。各种神经血管器械，包括血栓移除器械、微导管和血流转向线圈，都用于治疗这些疾病。根据世界中风组织 (WSO) 发布的《2024 年全球中风概况介绍》，每年将有超过 1,200 万例新发中风病例，全球约 25% 的人口一生中会经历中风。

中风等神经血管疾病的负担正在显着增加，预计将推动对神经血管设备（如血栓移除设备，包括血栓切除设备和抽吸设备）的需求。

目录

第一章调查方法与范围

第二章执行摘要

3. 神经血管装置变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 神经血管装置分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

4. 神经血管设备市场：依设备細項分析，2021-2033 年

  • 定义和范围
  • 2024 年及 2033 年各设备市场占有率分析
  • 2021-2033年全球神经血管设备市场（按设备）
  • 2021-2033 年市场规模、预测与趋势分析

5. 神经血管设备市场：細項分析（依治疗应用），2021 年至 2033 年

  • 定义和范围
  • 2024 年和 2033 年按治疗应用分類的市场占有率分析
  • 全球神经血管器材市场（依治疗应用），2021-2033
  • 2021-2033 年市场规模、预测与趋势分析

6. 神经血管设备市场：細項分析（依规模），2021 年至 2033 年

  • 定义和范围
  • 2024 年及 2033 年按规模分類的市场占有率分析
  • 2021-2033年全球神经血管器材市场规模
  • 2021-2033 年市场规模、预测与趋势分析

7. 神经血管设备市场：細項分析（依最终用途），2021-2033 年

  • 定义和范围
  • 2024 年和 2033 年按最终用途分類的市场占有率分析
  • 全球神经血管器材市场（依最终用途），2021-2033
  • 2021-2033 年市场规模、预测与趋势分析

第八章神经血管设备市场：区域估计和趋势分析

  • 区域仪表板
  • 市场规模、预测趋势分析，2021-2033年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 创新者
  • 供应商格局
  • 主要经销商和通路合作伙伴名单
  • 主要客户
  • 2024年主要企业市场占有率分析
    • Medtronic
    • Stryker
    • Terumo Corporation
    • Penumbra, Inc.
    • Johnson & Johnson and its affiliates
    • MicroPort Scientific Corporation
    • Acandis GmbH
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • NeuroSafe Medical Co., Ltd.
    • Rapid Medical
    • Evasc Neurovascular Enterprises
    • Lepu Medical Technology(Beijing)Co., Ltd.
    • phenox GmbH
  • 热图分析/企业市场分析
  • 2024年企业市场占有率预测分析
  • 其他主要市场公司名单
Product Code: GVR-2-68038-851-0

Neurovascular Devices Market Summary

The global neurovascular devices market size was estimated at USD 7.34 billion in 2024 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 5.48% from 2025 to 2033. The market is driven by the rising prevalence of neurovascular disorders, advancements in medical technology, and an increasing focus on minimally invasive procedures.

As conditions such as stroke, cerebral aneurysms, and Arteriovenous Malformations (AVM) become more common, the demand for effective treatment options also increases. The increasing prevalence of neurovascular diseases such as strokes and aneurysms is a major driving force behind the neurovascular devices industry. Various neurovascular devices, including clot retrieval devices, microcatheters, and flow diversion coils, are utilized to treat these conditions. According to the Global Stroke Fact Sheet 2024 published by the World Stroke Organization (WSO), more than 12 million new strokes occur annually, and about 25% of the global population will experience a stroke in their lifetime.

The burden of neurovascular disorders, such as strokes, is increasing significantly, which is anticipated to propel the demand for neurovascular devices such as neurothrombectomy devices like clot retrievers and suction devices, among others.

Global Neurovascular Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular devices market report based on the device, therapeutic application, size, end-use, and region:

  • Device Outlook (Revenue, USD Million, 2021 - 2033)
  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic coils
    • Flow diversion devices
    • Liquid embolic agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid artery stents
    • Embolic protection systems
  • Neurothrombectomy Devices
    • Clot retrieval devices
    • Suction devices/aspiration catheters
    • Vascular snares
  • Support Devices
    • Micro catheters
    • Micro guidewires
  • Trans Radial Access Devices
  • Therapeutic Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Stroke
  • Cerebral Artery
  • Cerebral Aneurysm
    • Aneurysmal Subarachnoid Hemorrhage
    • Others
  • Others
  • Size (in Inches) Outlook (Revenue, USD Million, 2021 - 2033)
  • 0.027"
  • 0.021"
  • 0.071"
  • 0.017"
  • 0.019"
  • 0.013"
  • 0.058"
  • 0.068"
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • KuwaitTable of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device
    • 1.2.2. Therapeutic Applications
    • 1.2.3. Size
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
      • 3.2.1.2. Technological Advancements in Neurovascular Devices
      • 3.2.1.3. Rising Number of Awareness Initiatives
      • 3.2.1.4. Increasing Demand for Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
      • 3.2.2.2. High Treatment Cost Associated with Neurovascular Disorders
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Number of Clinical Trials
      • 3.2.3.2. Launches of Novel Products
      • 3.2.3.3. Increasing Research & Development Activities
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of Skilled Professionals
      • 3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
  • 3.3. Neurovascular Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Device Market Share Analysis, 2024 & 2033
  • 4.3. Global Neurovascular Devices Market, by Device, 2021 to 2033
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 4.4.1. Cerebral Embolization and Aneurysm Coiling Devices
      • 4.4.1.1. Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
      • 4.4.1.2. Embolic coils
        • 4.4.1.2.1. Embolic coils market, 2021 - 2033 (USD Million)
      • 4.4.1.3. Flow diverters
        • 4.4.1.3.1. Flow diverters market, 2021 - 2033 (USD Million)
      • 4.4.1.4. Liquid embolic agents
        • 4.4.1.4.1. Liquid embolic agents market, 2021 - 2033 (USD Million)
    • 4.4.2. Cerebral angioplasty and stenting systems
      • 4.4.2.1. Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
      • 4.4.2.2. Carotid Artery Stents
        • 4.4.2.2.1. Carotid artery stents market, 2021 - 2033 (USD Million)
      • 4.4.2.3. Embolic Protection Devices
        • 4.4.2.3.1. Embolic protection systems devices market, 2021 - 2033 (USD Million)
    • 4.4.3. Neurothrombectomy devices
      • 4.4.3.1. Neurothrombectomy devices market, 2021 - 2033 (USD Million)
      • 4.4.3.2. Clot Retrieval Devices
        • 4.4.3.2.1. Clot retrieval devices market, 2021 - 2033 (USD Million)
      • 4.4.3.3. Suction Devices
        • 4.4.3.3.1. Suction devices market, 2021 - 2033 (USD Million)
      • 4.4.3.4. Vascular Snares
        • 4.4.3.4.1. Vascular snares market, 2021 - 2033 (USD Million)
    • 4.4.4. Support devices
      • 4.4.4.1. Support devices market, 2021 - 2033 (USD Million)
      • 4.4.4.2. Micro Catheters
        • 4.4.4.2.1. Micro catheters market, 2021 - 2033 (USD Million)
      • 4.4.4.3. Micro Guidewires
        • 4.4.4.3.1. Micro guidewires market, 2021 - 2033 (USD Million)
    • 4.4.5. Trans Radial Access Devices
      • 4.4.5.1. Trans radial access devices market, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Therapeutic Applications Market Share Analysis, 2024 & 2033
  • 5.3. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 5.4.1. Stroke
      • 5.4.1.1. Stroke market, 2021 - 2033 (USD Million)
    • 5.4.2. Cerebral artery stenosis
      • 5.4.2.1. Cerebral artery stenosis market, 2021 - 2033 (USD Million)
    • 5.4.3. Cerebral aneurysm
      • 5.4.3.1. Cerebral aneurysm market, 2021 - 2033 (USD Million)
      • 5.4.3.2. Aneurysmal Subarachnoid Hemorrhage
        • 5.4.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
      • 5.4.3.3. Others
      • 5.4.3.4. Others market, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By Size, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Size Market Share Analysis, 2024 & 2033
  • 6.3. Global Neurovascular Devices Market, by Size, 2021 to 2033
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 6.4.1. 0.027"
      • 6.4.1.1. 0.027" market, 2021 - 2033 (USD Million)
    • 6.4.2. 0.021"
      • 6.4.2.1. 0.021" market, 2021 - 2033 (USD Million)
    • 6.4.3. 0.071"
      • 6.4.3.1. 0.071" market, 2021 - 2033 (USD Million)
    • 6.4.4. 0.017"
      • 6.4.4.1. 0.017" market, 2021 - 2033 (USD Million)
    • 6.4.5. 0.019"
      • 6.4.5.1. 0.019" market, 2021 - 2033 (USD Million)
    • 6.4.6. 0.013"
      • 6.4.6.1. 0.013" market, 2021 - 2033 (USD Million)
    • 6.4.7. 0.058"
      • 6.4.7.1. 0.058" market, 2021 - 2033 (USD Million)
    • 6.4.8. 0.068"
      • 6.4.8.1. 0.068" market, 2021 - 2033 (USD Million)
    • 6.4.9. Others
      • 6.4.9.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2033
  • 7.3. Global Neurovascular Devices Market, by End Use, 2021 to 2033
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital market, 2021 - 2033 (USD Million)
    • 7.4.2. Specialty clinics
      • 7.4.2.1. Specialty clinics market, 2021 - 2033 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Others market, 2021 - 2033 (USD Million)

Chapter 8. Neurovascular Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Innovators
  • 9.4. Vendor Landscape
  • 9.5. List of key distributors and channel partners
  • 9.6. Key customers
  • 9.7. Global Key company market share analysis, 2024
    • 9.7.1. Medtronic
      • 9.7.1.1. Company overview
      • 9.7.1.2. Financial performance
      • 9.7.1.3. Product benchmarking
      • 9.7.1.4. Strategic initiatives
    • 9.7.2. Stryker
      • 9.7.2.1. Company overview
      • 9.7.2.2. Financial performance
      • 9.7.2.3. Product benchmarking
      • 9.7.2.4. Strategic initiatives
    • 9.7.3. Terumo Corporation
      • 9.7.3.1. Company overview
      • 9.7.3.2. Financial performance
      • 9.7.3.3. Product benchmarking
      • 9.7.3.4. Strategic initiatives
    • 9.7.4. Penumbra, Inc.
      • 9.7.4.1. Company overview
      • 9.7.4.2. Financial performance
      • 9.7.4.3. Product benchmarking
      • 9.7.4.4. Strategic initiatives
    • 9.7.5. Johnson & Johnson and its affiliates
      • 9.7.5.1. Company overview
      • 9.7.5.2. Financial performance
      • 9.7.5.3. Product benchmarking
      • 9.7.5.4. Strategic initiatives
    • 9.7.6. MicroPort Scientific Corporation
      • 9.7.6.1. Company overview
      • 9.7.6.2. Financial performance
      • 9.7.6.3. Product benchmarking
      • 9.7.6.4. Strategic initiatives
    • 9.7.7. Acandis GmbH
      • 9.7.7.1. Company overview
      • 9.7.7.2. Financial performance
      • 9.7.7.3. Product benchmarking
      • 9.7.7.4. Strategic initiatives
    • 9.7.8. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 9.7.8.1. Company overview
      • 9.7.8.2. Financial performance
      • 9.7.8.3. Product benchmarking
      • 9.7.8.4. Strategic initiatives
    • 9.7.9. NeuroSafe Medical Co., Ltd.
      • 9.7.9.1. Company overview
      • 9.7.9.2. Financial performance
      • 9.7.9.3. Product benchmarking
      • 9.7.9.4. Strategic initiatives
    • 9.7.10. Rapid Medical
      • 9.7.10.1. Company overview
      • 9.7.10.2. Financial performance
      • 9.7.10.3. Product benchmarking
      • 9.7.10.4. Strategic initiatives
    • 9.7.11. Evasc Neurovascular Enterprises
      • 9.7.11.1. Company overview
      • 9.7.11.2. Financial performance
      • 9.7.11.3. Product benchmarking
      • 9.7.11.4. Strategic initiatives
    • 9.7.12. Lepu Medical Technology(Beijing)Co., Ltd.
      • 9.7.12.1. Company overview
      • 9.7.12.2. Financial performance
      • 9.7.12.3. Product benchmarking
      • 9.7.12.4. Strategic initiatives
    • 9.7.13. phenox GmbH
      • 9.7.13.1. Company overview
      • 9.7.13.2. Financial performance
      • 9.7.13.3. Product benchmarking
      • 9.7.13.4. Strategic initiatives
  • 9.8. Heat Map Analysis/ Company Market Position Analysis
  • 9.9. Estimated Company Market Share Analysis, 2024
  • 9.10. List of Other Key Market Players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device
    • 1.2.2. Therapeutic Applications
    • 1.2.3. Size
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
      • 3.2.1.2. Technological Advancements in Neurovascular Devices
      • 3.2.1.3. Rising Number of Awareness Initiatives
      • 3.2.1.4. Increasing Demand for Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
      • 3.2.2.2. High Treatment Cost Associated with Neurovascular Disorders
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Number of Clinical Trials
      • 3.2.3.2. Launches of Novel Products
      • 3.2.3.3. Increasing Research & Development Activities
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of Skilled Professionals
      • 3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
  • 3.3. Neurovascular Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Device Market Share Analysis, 2024 & 2033
  • 4.3. Global Neurovascular Devices Market, by Device, 2021 to 2033
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 4.4.1. Cerebral Embolization and Aneurysm Coiling Devices
      • 4.4.1.1. Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
      • 4.4.1.2. Embolic coils
        • 4.4.1.2.1. Embolic coils market, 2021 - 2033 (USD Million)
      • 4.4.1.3. Flow diverters
        • 4.4.1.3.1. Flow diverters market, 2021 - 2033 (USD Million)
      • 4.4.1.4. Liquid embolic agents
        • 4.4.1.4.1. Liquid embolic agents market, 2021 - 2033 (USD Million)
    • 4.4.2. Cerebral angioplasty and stenting systems
      • 4.4.2.1. Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
      • 4.4.2.2. Carotid Artery Stents
        • 4.4.2.2.1. Carotid artery stents market, 2021 - 2033 (USD Million)
      • 4.4.2.3. Embolic Protection Devices
        • 4.4.2.3.1. Embolic protection systems devices market, 2021 - 2033 (USD Million)
    • 4.4.3. Neurothrombectomy devices
      • 4.4.3.1. Neurothrombectomy devices market, 2021 - 2033 (USD Million)
      • 4.4.3.2. Clot Retrieval Devices
        • 4.4.3.2.1. Clot retrieval devices market, 2021 - 2033 (USD Million)
      • 4.4.3.3. Suction Devices
        • 4.4.3.3.1. Suction devices market, 2021 - 2033 (USD Million)
      • 4.4.3.4. Vascular Snares
        • 4.4.3.4.1. Vascular snares market, 2021 - 2033 (USD Million)
    • 4.4.4. Support devices
      • 4.4.4.1. Support devices market, 2021 - 2033 (USD Million)
      • 4.4.4.2. Micro Catheters
        • 4.4.4.2.1. Micro catheters market, 2021 - 2033 (USD Million)
      • 4.4.4.3. Micro Guidewires
        • 4.4.4.3.1. Micro guidewires market, 2021 - 2033 (USD Million)
    • 4.4.5. Trans Radial Access Devices
      • 4.4.5.1. Trans radial access devices market, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Therapeutic Applications Market Share Analysis, 2024 & 2033
  • 5.3. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 5.4.1. Stroke
      • 5.4.1.1. Stroke market, 2021 - 2033 (USD Million)
    • 5.4.2. Cerebral artery stenosis
      • 5.4.2.1. Cerebral artery stenosis market, 2021 - 2033 (USD Million)
    • 5.4.3. Cerebral aneurysm
      • 5.4.3.1. Cerebral aneurysm market, 2021 - 2033 (USD Million)
      • 5.4.3.2. Aneurysmal Subarachnoid Hemorrhage
        • 5.4.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
      • 5.4.3.3. Others
      • 5.4.3.4. Others market, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By Size, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Size Market Share Analysis, 2024 & 2033
  • 6.3. Global Neurovascular Devices Market, by Size, 2021 to 2033
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 6.4.1. 0.027"
      • 6.4.1.1. 0.027" market, 2021 - 2033 (USD Million)
    • 6.4.2. 0.021"
      • 6.4.2.1. 0.021" market, 2021 - 2033 (USD Million)
    • 6.4.3. 0.071"
      • 6.4.3.1. 0.071" market, 2021 - 2033 (USD Million)
    • 6.4.4. 0.017"
      • 6.4.4.1. 0.017" market, 2021 - 2033 (USD Million)
    • 6.4.5. 0.019"
      • 6.4.5.1. 0.019" market, 2021 - 2033 (USD Million)
    • 6.4.6. 0.013"
      • 6.4.6.1. 0.013" market, 2021 - 2033 (USD Million)
    • 6.4.7. 0.058"
      • 6.4.7.1. 0.058" market, 2021 - 2033 (USD Million)
    • 6.4.8. 0.068"
      • 6.4.8.1. 0.068" market, 2021 - 2033 (USD Million)
    • 6.4.9. Others
      • 6.4.9.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2033
  • 7.3. Global Neurovascular Devices Market, by End Use, 2021 to 2033
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital market, 2021 - 2033 (USD Million)
    • 7.4.2. Specialty clinics
      • 7.4.2.1. Specialty clinics market, 2021 - 2033 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Others market, 2021 - 2033 (USD Million)

Chapter 8. Neurovascular Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2021 to 2033, (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Innovators
  • 9.4. Vendor Landscape
  • 9.5. List of key distributors and channel partners
  • 9.6. Key customers
  • 9.7. Global Key company market share analysis, 2024
    • 9.7.1. Medtronic
      • 9.7.1.1. Company overview
      • 9.7.1.2. Financial performance
      • 9.7.1.3. Product benchmarking
      • 9.7.1.4. Strategic initiatives
    • 9.7.2. Stryker
      • 9.7.2.1. Company overview
      • 9.7.2.2. Financial performance
      • 9.7.2.3. Product benchmarking
      • 9.7.2.4. Strategic initiatives
    • 9.7.3. Terumo Corporation
      • 9.7.3.1. Company overview
      • 9.7.3.2. Financial performance
      • 9.7.3.3. Product benchmarking
      • 9.7.3.4. Strategic initiatives
    • 9.7.4. Penumbra, Inc.
      • 9.7.4.1. Company overview
      • 9.7.4.2. Financial performance
      • 9.7.4.3. Product benchmarking
      • 9.7.4.4. Strategic initiatives
    • 9.7.5. Johnson & Johnson and its affiliates
      • 9.7.5.1. Company overview
      • 9.7.5.2. Financial performance
      • 9.7.5.3. Product benchmarking
      • 9.7.5.4. Strategic initiatives
    • 9.7.6. MicroPort Scientific Corporation
      • 9.7.6.1. Company overview
      • 9.7.6.2. Financial performance
      • 9.7.6.3. Product benchmarking
      • 9.7.6.4. Strategic initiatives
    • 9.7.7. Acandis GmbH
      • 9.7.7.1. Company overview
      • 9.7.7.2. Financial performance
      • 9.7.7.3. Product benchmarking
      • 9.7.7.4. Strategic initiatives
    • 9.7.8. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 9.7.8.1. Company overview
      • 9.7.8.2. Financial performance
      • 9.7.8.3. Product benchmarking
      • 9.7.8.4. Strategic initiatives
    • 9.7.9. NeuroSafe Medical Co., Ltd.
      • 9.7.9.1. Company overview
      • 9.7.9.2. Financial performance
      • 9.7.9.3. Product benchmarking
      • 9.7.9.4. Strategic initiatives
    • 9.7.10. Rapid Medical
      • 9.7.10.1. Company overview
      • 9.7.10.2. Financial performance
      • 9.7.10.3. Product benchmarking
      • 9.7.10.4. Strategic initiatives
    • 9.7.11. Evasc Neurovascular Enterprises
      • 9.7.11.1. Company overview
      • 9.7.11.2. Financial performance
      • 9.7.11.3. Product benchmarking
      • 9.7.11.4. Strategic initiatives
    • 9.7.12. Lepu Medical Technology(Beijing)Co., Ltd.
      • 9.7.12.1. Company overview
      • 9.7.12.2. Financial performance
      • 9.7.12.3. Product benchmarking
      • 9.7.12.4. Strategic initiatives
    • 9.7.13. phenox GmbH
      • 9.7.13.1. Company overview
      • 9.7.13.2. Financial performance
      • 9.7.13.3. Product benchmarking
      • 9.7.13.4. Strategic initiatives
  • 9.8. Heat Map Analysis/ Company Market Position Analysis
  • 9.9. Estimated Company Market Share Analysis, 2024
  • 9.10. List of Other Key Market Players

List of Figures

  • Fig. 1 Index of Figures
  • Fig. 2 Neurovascular devices market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modeling for market share assessment
  • Fig. 9 Market formulation & validation
  • Fig. 10 Market outlook (2024)
  • Fig. 11 Segment Outlook
  • Fig. 12 Strategy framework
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Neurovascular devices market: Device movement analysis
  • Fig. 19 Neurovascular devices market device outlook: Key takeaways
  • Fig. 20 Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
  • Fig. 21 Embolic coils market, 2021 - 2033 (USD Million)
  • Fig. 22 Flow diverters market, 2021 - 2033 (USD Million)
  • Fig. 23 Liquid embolic agents market, 2021 - 2033 (USD Million)
  • Fig. 24 Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
  • Fig. 25 Carotid artery stents market, 2021 - 2033 (USD Million)
  • Fig. 26 Embolic protection systems devices market, 2021 - 2033 (USD Million)
  • Fig. 27 Neurothrombectomy devices market, 2021 - 2033 (USD Million)
  • Fig. 28 Clot retrieval devices market, 2021 - 2033 (USD Million)
  • Fig. 29 Suction devices market, 2021 - 2033 (USD Million)
  • Fig. 30 Vascular snares market, 2021 - 2033 (USD Million)
  • Fig. 31 Support devices market, 2021 - 2033 (USD Million)
  • Fig. 32 Micro catheters market, 2021 - 2033 (USD Million)
  • Fig. 33 Guidewires market, 2021 - 2033 (USD Million)
  • Fig. 34 Trans radial access devices market, 2021 - 2033 (USD Million)
  • Fig. 35 Neurovascular devices market: Therapeutic application movement analysis
  • Fig. 36 Neurovascular devices market therapeutic applications outlook: Key takeaways
  • Fig. 37 Stroke market, 2021 - 2033 (USD Million)
  • Fig. 38 Cerebral artery stenosis market, 2021 - 2033 (USD Million)
  • Fig. 39 Cerebral aneurysm market, 2021 - 2033 (USD Million)
  • Fig. 40 Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
  • Fig. 41 Others market, 2021 - 2033 (USD Million)
  • Fig. 42 Neurovascular devices market: Size movement analysis
  • Fig. 43 Neurovascular devices market size outlook: Key takeaways
  • Fig. 44 0.027"market, 2021 - 2033 (USD Million)
  • Fig. 45 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 46 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 47 0.071" market, 2021 - 2033 (USD Million)
  • Fig. 48 0.046" market, 2021 - 2033 (USD Million)
  • Fig. 49 0.019" market, 2021 - 2033 (USD Million)
  • Fig. 50 0.013" market, 2021 - 2033 (USD Million)
  • Fig. 51 0.058" market, 2021 - 2033 (USD Million)
  • Fig. 52 0.068" market, 2021 - 2033 (USD Million)
  • Fig. 53 Others market, 2021 - 2033 (USD Million)
  • Fig. 54 Neurovascular devices market: End use movement analysis
  • Fig. 55 Neurovascular devices market end use outlook: Key takeaways
  • Fig. 56 Hospital market, 2021 - 2033 (USD Million)
  • Fig. 57 Specialty clinics market, 2021 - 2033 (USD Million)
  • Fig. 58 Others market, 2021 - 2033 (USD Million)
  • Fig. 59 Regional outlook, 2024 & 2033
  • Fig. 60 Regional market place: Key takeaways
  • Fig. 61 North America, SWOT, by PEST
  • Fig. 62 Europe, SWOT, by PEST
  • Fig. 63 Asia Pacific, SWOT, by PEST
  • Fig. 64 Latin America, SWOT, by PEST
  • Fig. 65 Middle East and Africa,, SWOT, by PEST
  • Fig. 66 North America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 67 U.S. neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 68 Canada neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 69 Europe neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 70 UK. neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 71 Germany neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 72 France neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 73 Italy neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 74 Spain neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 75 Norway neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 76 Denmark neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 77 Sweden neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 79 Japan neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 80 China neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 81 India neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 82 Australia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 83 South Korea neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 84 Thailand neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 85 Latin America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 86 Brazil neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 87 Mexico neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 88 Argentina neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 89 MEA neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 90 South Africa neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 91 Saudi Arabia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 92 UAE neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 93 Kuwait neurovascular devices market, 2021 - 2033 (USD Million)

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 5 North America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 6 North America neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 7 North America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 9 U.S neurovascular devices, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 10 U.S neurovascular devices, by size, 2021 - 2033 (USD Million)
  • Table 11 U.S neurovascular devices, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 13 Canada neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 14 Canada neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 15 Canada neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 18 Europe neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 19 Europe neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 20 Europe neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 21 UK neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 22 UK neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 23 UK neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 24 UK neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 26 Germany neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 27 Germany neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 28 Germany neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 30 France neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 31 France neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 32 France neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 34 Italy neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 35 Italy neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 36 Italy neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Spain neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 38 Spain neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 39 Spain neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 40 Spain neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Norway neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 42 Norway neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 43 Norway neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 44 Norway neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Sweden neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 46 Sweden neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 47 Sweden neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 48 Sweden neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 50 Denmark neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 51 Denmark neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 52 Denmark neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Asia Pacific neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 54 Asia Pacific neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 58 China neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 59 China neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 60 China neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 61 China neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Japan neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 63 Japan neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 64 Japan neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 65 Japan neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 66 India neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 67 India neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 68 India neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 69 India neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Australia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 71 Australia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 72 Australia neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 73 Australia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 74 South Korea neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 75 South Korea neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 76 South Korea neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 77 South Korea neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Latin America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 79 Latin America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 80 Latin America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 81 Latin America neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 82 Latin America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Brazil neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 84 Brazil neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 85 Brazil neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 86 Brazil neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Mexico neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 88 Mexico neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 89 Mexico neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 90 Mexico neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Argentina neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 92 Argentina neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 93 Argentina neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 94 Argentina neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Middle East & Africa neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 96 Middle East & Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 97 Middle East & Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 98 Middle East & Africa neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 99 Middle East & Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 100 South Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 101 South Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 102 South Africa neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 103 South Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 104 Saudi Arabia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 105 Saudi Arabia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 108 UAE neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 109 UAE neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 110 UAE neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 111 UAE neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Kuwait neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 113 Kuwait neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 114 Kuwait neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 115 Kuwait neurovascular devices market, by end use, 2021 - 2033 (USD Million)